A new type of pain medication to hit the market will create an alternative —it’s not an opioid — and could open the door to more drugs of this type in the future. CNN values your feedback 1.
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...
"Icons That Made Us" is a throwback series that celebrates the TV shows, movies, games and toys, and TV advertisements that shaped the lives of Singaporeans. From the laugh-out-loud comedies that ...
President Donald Trump said Sunday that Americans may feel economic "pain" from his tariffs on key trading partners, but argued it would be "worth the price" to secure US interests. On Saturday ...
In the quest for a reliable way to detect any stirrings of a sentient “I” in artificial intelligence systems, researchers are turning to one area of experience—pain—that inarguably unites ...
The US Food and Drug Administration has banned the use of red dye No. 3 in food, beverages and ingested drugs, more than 30 years after scientists discovered links to cancer in animals ...
Praveen Arany, University at Buffalo (THE CONVERSATION) Red light therapy is increasingly viewed as a promising treatment for wrinkles, acne, psoriasis, scars and sun-damaged skin, and as a ...
Now that the US Food and Drug Administration has banned red dye No. 3, many people are criticizing or questioning the safety and the FDA’s allowance of red dye No. 40 and five other color ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years. “Today’s approval is an important public health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
